Compounded versions of semaglutide marketed as injections have not undergone any testing nor been approved by the FDA and therefore make them unavailable for marketing as an approved drug
This gut-first approach makes it appealing to those who want a sustainable, non-invasive alternative to prescription medications
Dispense the preparation to the patient along with a 1 mL oral syringe to measure and administer the dose under the tongue
Overall, Lipo-C is often positioned as a research formulation for studying integrated metabolic pathways and nutrient-dependent cellular processes in laboratory settings
More studies are required to explore whether GLP-1 receptor agonists can cause specific types of pain and what mechanisms might be involved
doi: 10.3389/fnbeh.2026.1805953 Received 06 February 2026 Revised 13 March 2026 Accepted 13 March 2026 Published 13 April 2026 Volume 20 - 2026 Edited by Emmanuel Darcq, Institut National de la Sant et de la Recherche Mdicale (INSERM), France Reviewed by Zhe Zhao, Max Planck Florida Institute for Neuroscience (MPFI), United States Madhawi Aldhwayan, King Saud University, Saudi Arabia Updates Copyright 2026 OConnor